Skip to main content
. 2020 Apr 1;10:5787. doi: 10.1038/s41598-020-62448-3

Figure 3.

Figure 3

Cytotoxic activity of splenocytes against TC1 tumor cells. Mice were vaccinated three times with the each vaccine group or controls at one-week intervals, following inoculation with TC1 tumor cells. The splenocytes were co-cultured with TC1 cells for 6 to 8 h at an effector to target ratio (E:T) of 25:1. The CTL activity of the splenocytes was significantly increased in the mice immunized with pDNA-encapsulated archaeosomes and pDNA-surface localizated archaeosome group compared with that of the pDNA alone (pIRES-L1/E6/E7) and control groups (P < 0.0001). Data on the cytotoxicity induced by different treatments are presented as mean ± SD calculated from three experiments. (Abbreviations: pDNA + (S)Arch: pDNA-surface localized archaeosome; pDNA + (E)Arch: pDNA-encapsulated archaeosomes; pDNA: pDNA alone (L1/E6/E7 recombinant gene); Arch: archaeosomes alone (antigen-free archaeosomes); Mock Plasmid: pIRES.